← Back to News

Here Is Why AtaiBeckley (ATAI) Is One Of The 10 Best Stocks Under $10 That Could Triple

positiveMarket moveMulti dayYahoo Finance ·15 Jul 2026Original article ↗
Oraklio AI Analysis

Russell index inclusion can affect related Russell 2000 ETF flows (IWM) around effective dates, though the piece is primarily stock-specific and is not a direct IWM news item.

Article

Here Is Why AtaiBeckley (ATAI) Is One Of The 10 Best Stocks Under $10 That Could Triple Muhammad Ali Khalid Wed, July 15, 2026 at 5:43 PM GMT+2 2 min read ATAI ^RUT AtaiBeckley N. V. (NASDAQ: ATAI ) is one of the 10 best stocks under $10 that could triple .

On June 25, AtaiBeckley N. V. (NASDAQ:ATAI) shared that the company will be included in the Russell indices following their latest reconstitution.

The stock will become a part of the small-cap focused Russell 2000 Index, as well as the broader Russell 3000 Index, effective from June 29 onwards. Likoper/Shutterstock. com The company highlighted this as a significant development since more than $12 trillion worth of assets are benchmarked relative to the Russell indexes.

The Russell 2000 Index tracks around 2,000 small-cap stocks, while the Russell 3000 Index covers around 3,000 small-, mid-, and large-cap stocks. Later on July 7, Canaccord Genuity increased the price target on AtaiBeckley N. V.

(NASDAQ:ATAI) from $15 to $17, resulting in an adjusted upside potential of over 227%. The firm also reiterated its Buy rating on the stock. The price target revision came after the company revealed that it has concluded dosing for the final patient in relation to its Phase 2 Elumina trial of VLS-01 for treatment-resistant depression.

The company is targeting Phase 3 development for major depressive disorder, with a possibility of expanding into generalized anxiety disorder. AtaiBeckley N. V.

(NASDAQ:ATAI) is a clinical-stage biopharmaceutical company involved in the research, development, and commercialization of mental health therapies. The company's product pipeline consists of BPL-003 undergoing Phase 2 trials for treatment-resistant depression and alcohol addiction, as well as RL-007 being developed for cognitive decline from schizophrenia. While we acknowledge the potential of ATAI as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk.

If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the   best short-term AI stock . READ NEXT:  33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years . Disclosure: None.

Follow Insider Monkey on Google News .

Oraklio AI Trading Intelligence

News is just the start.

Oraklio turns news, price data, and market signals into structured BUY / SELL / NO_TRADE calls - updated continuously throughout the trading day.

Get started free

Already have an account? Sign in →